WHO ICTRP trial
Comparing the effect of Antipsychotic drugs with or without Cobalamin in…
IRCT201501101061N18 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201501101061N18 |
|---|---|
| Public title | Comparing the effect of Antipsychotic drugs with or without Cobalamin in elimination of pain and symptoms of psychosis in Alzheimer's patients |
| Scientific title | Comparing the effect of Quetiapine and Risperidone with or without Cobalamin in elimination of pain and symptoms of psychosis in Alzheimer's patients |
| Primary sponsor | Rafsanjan University of Medical Siences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Alzheimer disease. Alzheimer disease;Alzheimer disease |
| Interventions | Intervention 1: one group of Patients is treated randomly with quetiapine alone, 12.5 mgr in night and rise to 25 to 50 mg according to patient condition. Intervention 2: one group of Patients is treated randomly with Risperidone alone, 0.5… |
| Registration date | May 15, 2016 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: